Seattle Genetics | Revenu Net



Net Income Changement Date
AbbVie USD 1.29B 1.31B 2025-03
Acadia Pharmaceuticals USD 18.99M 124.76M 2025-03
Agios Pharmaceuticals USD -89289000 7.23M 2025-03
Amgen USD 1.73B 1.1B 2025-03
Astellas Pharma JPY 74.9B 172.56B 2025-03
Bayer EUR 1.3B 1.63B 2025-03
Biogen USD 240.5M 26.2M 2025-03
BioMarin Pharmaceutical USD 185.69M 60.74M 2025-03
Bristol-Myers Squibb USD 2.46B 2.38B 2025-03
Celldex Therapeutics USD -53796000 6.7M 2025-03
Daiichi Sankyo JPY 87.15B 25.22B 2025-03
Eisai JPY 949M 22.84B 2025-03
Eli Lilly USD 2.76B 1.65B 2025-03
Exelixis USD 159.62M 19.76M 2025-04
Genmab DKK 195M 3.65B 2025-03
Gilead Sciences USD 1.78B 529M 2024-12
GlaxoSmithKline GBP 1.62B 1.21B 2025-03
Glaxosmithkline GBP 414M 472M 2024-12
Incyte USD 158.2M 43.01M 2025-03
Insmed USD -256583000 21.04M 2025-03
MacroGenics USD -15421000 71.73M 2024-12
Merck USD 5.08B 1.34B 2025-03
Moderna USD -971000000 149M 2025-03
Novartis USD 2.82B 371M 2024-12
Pfizer USD 2.97B 2.56B 2025-03
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Sanofi EUR 1.87B 1.37B 2025-03
Sarepta Therapeutics USD -447508000 606.56M 2025-03
Takeda JPY -103155000000 126.94B 2025-03
Teva Pharmaceutical Industries USD 214M 431M 2025-03
Vertex Pharmaceuticals USD 913M 132.4M 2024-12
Xencor USD -48418000 5.06M 2025-03



Seattle Genetics Revenu Net - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.